Publication | Closed Access

Intraarterial Therapy with a New Potent Inhibitor of Tumor Metabolism (3-bromopyruvate): Identification of Therapeutic Dose and Method of Injection in an Animal Model of Liver Cancer

Tumor MetabolismOncologyHepatologyMedicineLiver PhysiologyHepatobiliary TumorPharmacotherapyLiver CancerAnti-cancer AgentPharmacologyRadiation OncologyHepatocellular CarcinomaCancer ResearchIntraarterial TherapyCancer MetabolismHealth Sciences